Stifel Downgrades Surgery Partners (SGRY) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Surgery Partners (SGRY) PT Lowered to $17 at Citi
August 11, 2017 8:42 AM EDTCiti lowered its price target on Surgery Partners (NASDAQ: SGRY) to $17.00 (from $28.00) while maintaining a Buy rating.
... MoreRaymond James Downgrades Surgery Partners (SGRY) to Market Perform
August 9, 2017 3:52 AM EDTRaymond James downgraded Surgery Partners (NASDAQ: SGRY) from Strong Buy to Market Perform.
For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.
Shares of Surgery Partners closed at $19.15 yesterday.
... MoreKeyBanc Downgrades Surgery Partners (SGRY) to Sector Weight
August 9, 2017 3:45 AM EDTKeyBanc downgraded Surgery Partners (NASDAQ: SGRY) from Overweight to Sector Weight.
For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.
Shares of Surgery Partners closed at $19.15 yesterday.
... MoreSurgery Partners, Inc. (SGRY) Misses Q2 EPS by 27c, Miss on Revenues; Offers FY17 Revenues
August 8, 2017 4:15 PM EDTSurgery Partners, Inc. (NASDAQ: SGRY) reported Q2 EPS of ($0.09), $0.27 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $288.4 million versus the consensus estimate of $314.22 million.
Full Year 2017 Guidance
For 2017, the Company is modifying the guidance provided on our conference call in March... More
